Navigation Links
WellPoint Highlights Operational Accomplishments and Details 2009 Guidance at Annual Investor Meeting
Date:2/24/2009

s and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include: those discussed and identified in our public filings with the SEC; increased government regulation of health benefits, managed care and pharmacy benefit management operations; trends in health care costs and utilization rates; our ability to secure sufficient premium rate increases; our ability to contract with providers consistent with past practice; competitor pricing below market trends of increasing costs; reduced enrollment, as well as a negative change in our health care product mix; risks and uncertainties regarding the Medicare Part C and Part D Prescription Drug benefits programs, including those related to CMS sanctions, potential uncollectability of receivables resulting from processing and/or verifying enrollment (including facilitated enrollment), inadequacy of underwriting assumptions, inability to receive and process correct information, uncollectability of premium from members, increased medical or pharmaceutical costs, and the underlying seasonality of the business; a downgrade in our financial strength ratings; litigation and investigations targeted at health benefits companies and our ability to resolve litigation and investigations within estimates; our ability to meet expectations regarding repurchases of shares of our common stock; funding risks with respect to revenue received from participation in Medicare and Medicaid programs; non-compliance with the complex regulations imposed on Medicare and Medic
'/>"/>
SOURCE WellPoint, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. WellPoint Announces Appearances at Upcoming Conferences
2. WellPoint and M-Plan Enter Into Endorsement Agreement as M-Plan Announces Exit From the Commercial HMO Business in Indiana
3. WellPoint Announces Realignment of Core Businesses; Names New Executives
4. Wellpoint NextRx Receives TIPPS Certification from the HR Policy Association
5. WellPoint NextRx Receives National Leadership Award for Innovative Web Tool
6. WellPoint Reports Third Quarter 2007 Results
7. WellPoint Taps Zagat Survey to Help Consumers Rate Experiences with Their Doctors
8. WellPoint Provides Support and Resources to Most Vulnerable California Residents
9. WellPoint Announces Appointment of John Cannon III as Executive Vice President & General Counsel
10. WellPoint Highlights 2007 Accomplishments and Strong 2008 Outlook at Annual Investor Meeting
11. WellPoint Announces Appointment of John Langenus as President of Anthem National Accounts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... San Diego, CA (PRWEB) October 20, 2014 ... regarding all the latest information from the FDA on ... consumers on October 10 not to purchase or use Sit ... Phenolphthalein. Sit and Slim II is promoted as weight loss ... , Sibutramine, removed from the market in 2010 for safety ...
(Date:10/20/2014)... OH (PRWEB) October 20, 2014 ... Assisted Living Center on Oct. 14. The $11 million ... and services, and a cooked-to-order kitchen with full-service restaurant ... Akron’s premier choice for first class Assisted Living apartments,” ... “Our residents deserve the highest quality of care and ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Based ... are the only imaging assays capable of determining ... single test.  With these three dimensions of high-resolution ... to detect the widest range of disease-causing genetic ... missed by other genomic tools, including today’s advanced ...
(Date:10/20/2014)... Aliso Viejo, California (PRWEB) October 20, 2014 ... have announced the release of the Citrus theme for ... words I would use to describe the Citrus theme” Says ... been so easy to look so professional.” , Citrus comes ... . Included with the template are: four transitions for added ...
(Date:10/20/2014)... hard to imagine what it’s like to live without shoes, ... it’s a reality. And while new shoes are considered a ... barefoot on rocky terrain or sewage-lined streets just to collect ... , Buckner International's Shoes for Orphan Souls project ... encourage support for Air1 and while also providing new shoes ...
Breaking Medicine News(10 mins):Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Rockynol Retirement Community Expands Assisted Living Center 2Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3
... learned that you were at high risk of cancer because ... your children? A recent study at Fox Chase Cancer Center ... the next level and studied the parent perceptions of the ... be presented at the 2009 Annual Meeting of the American ...
... Chase Cancer Center uncovered a genetic pattern that may ... to the targeted therapy imatinib mesylate (Gleevec). Moreover, ... in order to make these tumors respond more readily ... in the laboratory of Andrew K. Godwin, PhD, at ...
... new pharmaceutical products in the pipeline combined with new ... the rare disease community, a senior Food and Drug ... by the National Organization for Rare Disorders (NORD).The blockbuster ... director of the Center for Drug Evaluation and Research ...
... 14 Hanger Orthopedic Group Inc. (NYSE: ... in the S&P SmallCap 600 after the close of trading ... acquired by privately held TriNet Group, Inc. in a transaction ... and post any relevant updates on its website: ...
... MedServe, Inc., a private company, today announced that it ... Stericycle, Inc. (Nasdaq: SRCL ) for $185 ... Avista Capital Partners, Chrysalis Ventures and Murphree Venture Partners ... collection, transportation, treatment and disposal of medical waste, hazardous ...
... ImQuest Bio and Arisyn jointly presented important ... inhibitor of hepatitis C virus (HCV) replication, at the 13th ... presentation highlighted the ability of PG301029 to potently suppress the ... potential mechanism of antiviral action through the selection of a ...
Cached Medicine News:Health News:Should parents share the results of BRCA1/2 genetic testing with their children? 2Health News:Gene signature may predict patient response to therapy for gastrointestinal stromal tumors 2Health News:NORD Sponsors Rare Disease Summit 2Health News:Standard & Poor's Announces Changes to U.S. Index 2Health News:MedServe to be Acquired by Stericycle for $185 Million 2Health News:MedServe to be Acquired by Stericycle for $185 Million 3Health News:ImQuest BioSciences and Arisyn Therapeutics Introduce Novel New HCV Therapeutic Agent at Hepatitis Conference 2
(Date:10/17/2014)... UBM Medica US announces that Neurology Times ... for neurologists and other healthcare providers, features special coverage on ... discussions of the latest developments in approaches to diagnosis. ... , more than the total of those who have multiple ... can be difficult because there are no confirmatory medical tests. ...
(Date:10/17/2014)... Oct. 17, 2014 A victim of medical negligence ... doctor with a history of alcohol abuse, a physician ... on Prop 46 today, highlighting how Prop 46 will identify ... testing. The ad pictures a doctor drinking ... To ER."  Proposition 46 will enact the first law in ...
(Date:10/17/2014)... 2014   InnFocus, Inc ., reported on results of ... for up to 3 years with the InnFocus ... Chicago . The Summit ... meeting of the American Academy of Ophthalmology . The ... glaucoma patients in 6 countries by early 2015. ...
Breaking Medicine Technology:Neurology Times Features Coverage of Parkinson and Alzheimer Disease 2Neurology Times Features Coverage of Parkinson and Alzheimer Disease 3Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 2Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 3Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 4InnFocus Featured at the Ophthalmology Innovation Summit In Chicago 2
... LITTLE FALLS, N.J. , May 26 CANTEL ... Andrew A. Krakauer , President & CEO, will be presenting at the ... 9:00 AM ET on Wednesday, June 9, 2010 ... a Q & A session immediately following the presentation. In addition, Mr. ...
... BOSTON , May 26 Solos Endoscopy, Inc. ... $104,774 in revenues for the first quarter ended ... the first quarter 2009, which represents a 10 percent increase. As ... in total assets. The Company has posted its financial results for ...
Cached Medicine Technology:Cantel Medical Corp. to Present at the Jefferies 2010 Global Life Sciences Conference 2Solos Endoscopy, Inc. Increases Revenues by 10 Percent for First Quarter 2010 as Compared to First Quarter 2009 2
Claes Shielded Retinotomy Scissors, Vertical...
... DxSelect is intended for qualitatively detecting antibodies ... serum. The test is indicated for testing ... an aid in the presumptive laboratory diagnosis ... intended for self-testing, and this test is ...
... Indirect immunofluorescent antibody (IFA) test for ... IgG antibodies to St. Louis Encephalitis virus ... Equine Encephalitis virus (EEE), and California Encephalitis/La ... 8-well slides with fixed individual spots of ...
... immunofluorescent antibody (IFA) test ... semi-quantitation of human serum ... viral capsid antigen (VCA). ... 12-well slides, FITC IgG ...
Medicine Products: